Bard Promotes Sharon M. Alterio to Group Vice President
More News related to BCR
- C. R. Bard (BCR) Publishes Study Results of Agento(R) I.C. Endotracheal Tube in JAMA
- JAMA Publishes Study Results on Efficacy of the Bard Agento(R) I.C. Silver-Coated Endotracheal Tube in Preventing Ventilator-Associated Pneumonia
- Court Rules in Favor of Bard on Patent Infringement Suit against W. L. Gore & Associates
- David Moenning's Daily State of the Markets:
- C.R. Bard, Inc. (BCR) Beats By 2c
More News related to Press Releases
- Most Voters and Catholics Would Oppose a President Who Doesn't Know When Life Begins
- International Millennium Mining Corp.: 2nd Quarter 2008 Report
- WCSB GORR Oil & Gas Income Participation 2008-I Limited Partnership Offering Closed August 28th, 2008-$6,694,600 Raised
- Operation HOPE Announces Support for the New FDIC Loan Modification Program for Distressed IndyMac FSB Mortgage Loans
- Internet Allows Public to Show Support for VP Candidates in Record Time
MURRAY HILL, N.J.--(BUSINESS WIRE)--
C. R. Bard, Inc. (NYSE: BCR) announced today that Sharon M. Alterio, 45, has been promoted to the position of Group Vice President with responsibility for Bard's international businesses, effective December 1, 2008. Sharon replaces Amy S. Paul, who will retire from Bard at the end of the year after 26 years of service.
Sharon joined Bard in October 2004 as President of Bard Medical Division (BMD). Under her leadership, BMD acquired Venetec International, Inc. in 2006, which brought the StatLock(R) catheter stabilization product line into the division's portfolio. Sharon's team also completed Bard's largest clinical trial, which resulted in FDA clearance in late 2007 to market the Agento(TM) IC silver-coated endotracheal tube for the prevention of ventilator assisted pneumonia.
Prior to joining Bard, Sharon worked at Baxter Healthcare in a number of positions of increasing responsibility, most recently as Vice President, Global Therapeutic Marketing for the Renal Division. Sharon earned a Bachelor of Science degree in Computer Science and a Masters of Management degree from Northwestern University.
C. R. Bard, Inc. (www.crbard.com), headquartered in Murray Hill, N.J., is a leading multinational developer, manufacturer and marketer of innovative, life-enhancing medical technologies in the fields of vascular, urology, oncology and surgical specialty products.
Source: C. R. Bard, Inc.
Related Categories
Press ReleasesStocks Mentioned
-1.46Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
